|
[1]
|
Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70(1):1 − 25. http://dx.doi.org/10.1016/j.jacc.2017.04.052CrossRef
|
|
[2]
|
Lee JH, Kim HC, Kang DR, Suh I. The 23-year tracking of blood lipids from adolescence to adulthood in Korea: the Kangwha study. Lipids Health Dis 2017;16(1):221. http://dx.doi.org/10.1186/s12944-017-0615-2CrossRef
|
|
[3]
|
Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, et al. Lipid screening in childhood and adolescence for detection of familial hypercholesterolemia: evidence report and systematic review for the US preventive services task force. JAMA 2016;316(6):645 − 55. http://dx.doi.org/10.1001/jama.2016.6176CrossRef
|
|
[4]
|
Chi XP, Zhao LY, Yu DM, Fang HY, Ju LH. Relevant effects of pathoglycemia in Chinese children and adolescents aged 6-17 in 2016-2017. J Hyg Res 2021;50(5):708 − 15. http://dx.doi.org/10.19813/j.cnki.weishengyanjiu.2021.05.002 (In Chinese). CrossRef
|
|
[5]
|
Editorial Board of Chinese Journal of Pediatrics, Subspecialty Group of Child Health Care, The Society of Pediatrics, Chinese Medical Association, Subspecialty Group of Cardiovascular Disease, The Society of Pediatrics, Chinese Medical Association, Subspecialty Group of Atherosclerosis, The Society of Cardiovascular, Disease, Chinese Medical Association. Expert consensus for prevention and treatment of dyslipidemia in children and adolescents. Chin J Pediatr 2009;47(6):426 − 8. http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2009.06.007 (In Chinese). CrossRef
|
|
[6]
|
Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128 Suppl 5(Suppl 5):S213-56. http://dx.doi.org/10.1542/peds.2009-2107C.http://dx.doi.org/10.1542/peds.2009-2107C |
|
[7]
|
Wang R, Zhang HD, Hu YC, Chen J, Yang ZY, Zhao LY, et al. Serum vitamin a nutritional status of children and adolescents aged 6−17 years — China, 2016−2017. China CDC Wkly 2021;3(9):189 − 92. http://dx.doi.org/10.46234/ccdcw2021.057CrossRef
|
|
[8]
|
He HJ, Pan L, Du JW, Liu F, Jin YM, Ma JG, et al. Prevalence of, and biochemical and anthropometric risk factors for, dyslipidemia in children and adolescents aged 7 to 18 years in China: a cross-sectional study. Am J Hum Biol 2019;31(5):e23286. http://dx.doi.org/10.1002/ajhb.23286CrossRef
|
|
[9]
|
Li YQ, Jia SS, Liu BB, Fang HY, Ding XY, Zhang J, et al. Dyslipidemia among 12-17 years children in western region of China: a cross-sectional analysis, 2016-2017. Chin J Public Health 2021;37(10):1508 − 13. http://dx.doi.org/10.11847/zgggws1131893 (In Chinese). CrossRef
|
|
[10]
|
Laskarzewski PM, Morrison JA, Gutai J, Khoury PR, Glueck CJ. Longitudinal relationships among endogenous testosterone, estradiol, and Quetelet index with high and low density lipoprotein cholesterols in adolescent boys. Pediatr Res 1983;17(8):689 − 98. http://dx.doi.org/10.1203/00006450-198308000-00018CrossRef
|
|
[11]
|
Cheng H, Xiao P, Hou DQ, Gao AY, Wang LG, Yu ZC, et al. Epidemiological characteristics and related factors of dyslipidemia among Beijing children and adolescents aged 6-16 years in 2017. Chin Circ J 2020;35(6):566 − 72. http://dx.doi.org/10.3969/j.issn.1000-3614.2020.06.008 (In Chinese). CrossRef
|
|
[12]
|
Chinese Medical Association Diabetes Society Metabolic Syndrome Research Collaborative Group. Suggestions of Chinese medical association diabetes society on metabolic syndrome. Chin J Diabetes 2004;12(3):156 − 61. http://dx.doi.org/10.3321/j.issn:1006-6187.2004.03.002 (In Chinese). CrossRef
|